HIGHLIGHTS
- who: Unknown from the Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Medical University School of Medicine, Japan have published the research: Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial, in the Journal: (JOURNAL) of June/11,/2023
- what: The aim of the investigator -initiated clinical trial is to assess the safety and potential efficacy of the intravenous infusion of autoserum-expanded autologous MSCs for patients with chronic brain injury. The authors propose to provide an extensive rehabilitation protocol to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.